New Delhi, July 18 (IANS) At a time when global supply chains are getting rejigged, if India can do the right reforms, it could become a meaningful producer and exporter of goods, which could spur investment, credit and GDP growth, an HSBC report said on Friday.
New Delhi, July 18 (IANS) India is set to lead the global creative economy with AI-driven innovation, as the startup ecosystem surges especially in the tier 2 and 3 cities, according to the government.
New Delhi, July 17 (IANS) Shubhanshu Shukla, who returned from the International Space Station (ISS) early this week, is in stable condition, said the Indian Space Research Organisation (ISRO) on Thursday.
Mumbai, July 17 (IANS) Tech giant Wipro on Thursday reported an 11.1 per cent increase in its consolidated net profit for the April-June quarter (Q1) of FY26, reaching Rs 3,336.5 crore, compared to Rs 3,003 crore in the same quarter previous year.
Mumbai, July 17 (IANS) Waaree Renewable Technologies on Thursday reported a decline of 8.51 per cent in net profit on a sequentially basis to Rs 86.3 crore in the June quarter (Q1 FY26), compared to the previous quarter (Q4 FY25), where it had reported Rs 94 crore in net profit.
Mumbai, July 17 (IANS) The Indian stock market settled in negative territory on Thursday following selling in IT and banking stocks amid Q1 earnings, and FII outflows due to trade deal concerns.
New Delhi, July 17 (IANS) Apple has set a new benchmark in smartphone manufacturing in India, achieving its fastest-ever growth in iPhone production as well as exports during the first half of 2025, the government said on Thursday.
New Delhi, July 17 (IANS) The Indian medical tourism market is set to surge from $18.2 billion in 2025 to $58.2 billion by 2035, according to a new report on Thursday.
New Delhi, July 17 (IANS) Homegrown company Newgen Software on Thursday reported a sharp drop in its quarterly performance for Q1 FY26, with net profit falling by 54.11 per cent to Rs 49.72 crore from Rs 108.33 crore in the previous quarter (Q4 FY25).
New Delhi, July 17 (IANS) A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its use can potentially lead to recurrence-free survival in patients with pulmonary TB, according to a recent study by the Indian Council of Medical Research (ICMR).
